Literature DB >> 24531749

Prognostic significance of TBX2 expression in non-small cell lung cancer.

Bo Hu1, Hai-Ping Mu, Yu-Qing Zhang, Chong-Yi Su, Jian-Tao Song, Chong Meng, Dong-Xing Liu.   

Abstract

T-box2 (TBX2) expression has been reported to be related to aggressive tumor features. However, the role of TBX2 in non-small-cell lung cancer (NSCLC) tumorigenesis has never been elucidated. So we aimed at investigating the potential role of TBX2 in NSCLC. TBX2 expression was evaluated by qRT-PCR and Western blotting in 50 paired fresh lung cancer tissues as well as immunohistochemistry on 212 paraffin-embedded sections. We showed that the expression level of TBX2 was significantly increased in NSCLC as compared with the adjacent noncancerous tissue. Positive expression level of TBX2 was associated with histological type, lymph node metastasis and distant metastasis. Kaplan-Meier survival curves showed that positive expression level of TBX2 was associated with poor overall survival (OS) and progression-free survival of NSCLC patients. Results showed that TBX2 positivity was an independent prognostic factor for OS (HR 1.87, 95% CI 1.004-3.153, p = 0.012). On the basis of these results, we suggested that TBX2 protein expression may be an unfavorable independent prognostic parameter for NSCLC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24531749     DOI: 10.1007/s10735-014-9569-0

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  15 in total

1.  Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.

Authors:  Raju Kandimalla; Angela A G van Tilborg; Lucie C Kompier; Dominique J P M Stumpel; Ronald W Stam; Chris H Bangma; Ellen C Zwarthoff
Journal:  Eur Urol       Date:  2012-01-18       Impact factor: 20.096

2.  Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy.

Authors:  Tomoshi Tsuchiya; Shinji Akamine; Masashi Muraoka; Ryotaro Kamohara; Koichi Tsuji; Shogo Urabe; Sumihisa Honda; Naoya Yamasaki
Journal:  Lung Cancer       Date:  2007-03-09       Impact factor: 5.705

Review 3.  Predictive markers in the adjuvant therapy of non-small cell lung cancer.

Authors:  Martin Filipits; Robert Pirker
Journal:  Lung Cancer       Date:  2011-08-31       Impact factor: 5.705

Review 4.  Staging of non-small cell lung cancer (NSCLC): a review.

Authors:  S Tsim; C A O'Dowd; R Milroy; S Davidson
Journal:  Respir Med       Date:  2010-09-15       Impact factor: 3.415

5.  Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas.

Authors:  Keith W Vance; Suzanne Carreira; Gerald Brosch; Colin R Goding
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

6.  Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.

Authors:  J J Jacobs; P Keblusek; E Robanus-Maandag; P Kristel; M Lingbeek; P M Nederlof; T van Welsem; M J van de Vijver; E Y Koh; G Q Daley; M van Lohuizen
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

Review 7.  The T-box transcription factor Tbx2: its role in development and possible implication in cancer.

Authors:  Amaal Abrahams; M Iqbal Parker; Sharon Prince
Journal:  IUBMB Life       Date:  2010-02       Impact factor: 3.885

8.  Tbx2 directly represses the expression of the p21(WAF1) cyclin-dependent kinase inhibitor.

Authors:  Sharon Prince; Suzanne Carreira; Keith W Vance; Amaal Abrahams; Colin R Goding
Journal:  Cancer Res       Date:  2004-03-01       Impact factor: 12.701

9.  A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance.

Authors:  S Wansleben; E Davis; J Peres; S Prince
Journal:  Cell Death Dis       Date:  2013-10-10       Impact factor: 8.469

10.  Tbx2 controls lung growth by direct repression of the cell cycle inhibitor genes Cdkn1a and Cdkn1b.

Authors:  Timo H-W Lüdtke; Henner F Farin; Carsten Rudat; Karin Schuster-Gossler; Marianne Petry; Phil Barnett; Vincent M Christoffels; Andreas Kispert
Journal:  PLoS Genet       Date:  2013-01-17       Impact factor: 5.917

View more
  12 in total

1.  Transformer 2β (Tra2β/SFRS10) positively regulates the progression of NSCLC via promoting cell proliferation.

Authors:  Lili Ji; Tingting Ni; Yanbo Shen; Qun Xue; Yifei Liu; Buyou Chen; Xuefan Cui; Liting Lv; Xiafei Yu; Yuan Cui; Xiaoning Lu; Jie Chen; Guoxin Mao; Yuchan Wang
Journal:  J Mol Histol       Date:  2014-06-21       Impact factor: 2.611

2.  Prognostic value of decreased GRK6 expression in lung adenocarcinoma.

Authors:  Sumei Yao; Lou Zhong; Jian Liu; Jia Feng; Tingting Bian; Qing Zhang; Jinliang Chen; Xuedong Lv; Jianrong Chen; Yifei Liu
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-06       Impact factor: 4.553

3.  Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis.

Authors:  Wubin Ding; Geng Chen; Tieliu Shi
Journal:  Epigenetics       Date:  2019-01-29       Impact factor: 4.528

4.  Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis.

Authors:  Tingting Ni; Guoxin Mao; Qun Xue; Yifei Liu; Buyou Chen; Xuefan Cui; Liting Lv; Liangliang Jia; Yuchan Wang; Lili Ji
Journal:  J Mol Histol       Date:  2015-06-10       Impact factor: 2.611

5.  Selective expression of transthyretin in subtypes of lung cancer.

Authors:  Shuai Hao; Suozhu Sun; Xueyuan Xiao; Dacheng He; Liyun Liu
Journal:  J Mol Histol       Date:  2016-03-04       Impact factor: 2.611

6.  The reverse effect of X-ray irradiation on acquired gefitinib resistance in non-small cell lung cancer cell line NCI-H1975 in vitro.

Authors:  Jing Wang; Hong Wei; Baoxia Zhao; Mei Li; Weipeng Lv; Ling Lv; Bo Song; Shen Lv
Journal:  J Mol Histol       Date:  2014-07-10       Impact factor: 2.611

7.  Putative Breast Cancer Driver Mutations in TBX3 Cause Impaired Transcriptional Repression.

Authors:  Kathrin Fischer; Gert O Pflugfelder
Journal:  Front Oncol       Date:  2015-10-29       Impact factor: 6.244

8.  Tbx2 confers poor prognosis in glioblastoma and promotes temozolomide resistance with change of mitochondrial dynamics.

Authors:  Fuxin Yi; Jianzhou Du; Weimin Ni; Weixian Liu
Journal:  Onco Targets Ther       Date:  2017-02-20       Impact factor: 4.147

9.  TBX2 subfamily suppression in lung cancer pathogenesis: a high-potential marker for early detection.

Authors:  Athar A Khalil; Smruthy Sivakumar; Frances Anthony San Lucas; Tina McDowell; Wenhua Lang; Kazuhiro Tabata; Junya Fujimoto; Yasushi Yatabe; Avrum Spira; Paul Scheet; Georges Nemer; Humam Kadara
Journal:  Oncotarget       Date:  2017-08-04

10.  TBX2 over-expression promotes nasopharyngeal cancer cell proliferation and invasion.

Authors:  Yan Lv; Meng Si; Nannan Chen; Ya Li; Xingkai Ma; Huijun Yang; Ling Zhang; Hongyan Zhu; Guang-Yin Xu; Ge-Ping Wu; C Cao
Journal:  Oncotarget       Date:  2017-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.